Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - HELIUS MEDICAL TECHNOLOGIES, INC. | exhibit99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 6, 2016 (January 4, 2016)
HELIUS MEDICAL TECHNOLOGIES,
INC.
(Exact Name of Registrant as Specified in
Charter)
| Wyoming | 000-55364 | 36-4787690 |
| (State or Other Jurisdiction | (Commission | (IRS Employer |
| of Incorporation) | File Number) | Identification No.) |
| Suite 400, 41 University Drive | |
| Newtown, Pennsylvania | 18940 |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant's telephone number, including area code (215) 809-2018
_________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 Other Events.
On January 4, 2016, Helius Medical Technologies, Inc. issued a press release to announce the allowance of 10 new patents related to its Portable Neuromodulation Stimulator (PoNS TM ) 4.0 device. The text of the press release is included as Exhibit 99.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
| (d) |
Exhibits: |
| Exhibit | Description |
| Number | |
| 99.1 | Press Release, dated January 4, 2016. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HELIUS MEDICAL TECHNOLOGIES, INC.
Date: January 6, 2016
| By: | /s/ Joyce LaViscount |
| Name: | Joyce LaViscount |
| Title: | Chief Financial Officer |
Exhibit Index
| Exhibit Number | Description |
| 99.1 | Press Release, dated January 4, 2016. |
2